Drugs that contain Topiramate

1. Drug name - QUDEXY XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10363224 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US8889190 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US9101545 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US9555005 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US8652527 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

Treatment: Treatment of seizures

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
25MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
150MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

2. Drug name - TROKENDI XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9555004 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US8992989 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US8889191 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US9549940 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US8298580 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US8877248 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US10314790 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US9622983 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US8663683 SUPERNUS PHARMS Sustained-release formulations of topiramate Nov, 2027

(5 years from now)

US8298576 SUPERNUS PHARMS Sustained-release formulations of topiramate Apr, 2028

(5 years from now)

Treatment: Use of trokendi xr for prophylactic treatment of migraine; use of trokendi xr for the treatment of epilepsy; Use of trokendi xr for the treatment of epilepsy; use of trokendi xr for prophylactic treatment of migraine; Treatment of epilepsy; use of trokendi xr for prophylactic treatment of migraine; Use of trokendi xr for prophylactic treatment of migraine; treatment of epilepsy

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
25MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.